Seroprevalence of IgM and IgG Against SARS-CoV-2 after Two Doses of Pfizer-BioNTech COVID-19 Vaccine in Women with Breast Cancer.

Mazen Almehmadi,Magdi M Salih,Alaa Shafie,Abdulaziz Alsharif, Naif Alsiwiehr,Ahmad El-Askary,Khalid Alzahrani,Ayman Al-Hazmi,Abdulelah Aljuaid, Osama Abdulazziz,Abdulraheem A Almalki,Mamdouh Allahyani,Emad Eed,Ahmad M Alharbi,Mustafa Halawi,Hatem H Allam, Hisham Abutawil,Ebtisam Alosimi,Amal F Gharib

Clinical laboratory（2022）

引用 0|浏览5

暂无评分

摘要

Our results recommend the importance of screening for an antibody response for breast cancer patient after immunization in order to reveal persons who need early and late extra enhancing vaccine dose. Upcoming studies recommended to estimate different methods that raise cancer patients' immune response.

查看译文

关键词

breast cancer,COVID-19 vaccination,IgM and IgG antibodies

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要